- Our organization brings years of expertise in managing the care of dialysis and cancer patients, positioning us to meet both the current and future healthcare demands. We are fully dedicated to delivering comprehensive solutions across patient care, hospitals, trade, exports, manufacturing, and services, all aimed at enhancing the quality of life in an affordable manner for the greater good of society.
- With a highly skilled and dedicated team spread across various departments, we are working diligently to achieve our organizational goals. As we look to scale our operations, we are focused on aligning our resources and strategies to maximize our impact within the set timeframe.
- To further streamline our operations and ensure sustainable growth, we are establishing a robust leadership framework, including key executive positions such as CEO, CFO, COO, CMO, Presidents, and Vice Presidents, to drive strategic initiatives and deliver exceptional results.
About
Hippocrat BioTech Group of Companies
Hippocrat Group of Companies began with the establishment of Hippocrat Biotech Pvt. Ltd. in 2013, focusing on wholesale, retail, distribution, and export. In the same year, Biorealm Biopharmaceuticals was incorporated, specializing in marketing its own brand of dialysis injectables. The group was founded by its two directors, Mr. Neeraj Kumar and Mrs. Suneeta Devi.
In 2023, the company expanded significantly by launching its own manufacturing unit for dialysis products under Hippocrat Biomedical LLP, supported by a large corporate office. Additionally, the group established Hippocrat Dialysis Services Pvt. Ltd., dedicated to providing professional dialysis services.
